How Fast Does Semaglutide Work? Complete Timeline

    By Trimi Medical Team5 min read

    Semaglutide starts working within days, but visible results take weeks to months. Appetite reduction is typically noticeable within 1-2 weeks. Meaningful weight loss becomes apparent at 4-8 weeks. Maximum results are reached at 12-16 months of treatment at the full maintenance dose. Here is the evidence-based timeline.

    Medical Disclaimer: This article is for informational purposes only. Individual results vary significantly. Always follow your provider's dosing and titration schedule.

    The Quick Answer

    • Appetite changes: 1-2 weeks
    • First noticeable weight loss: 4-8 weeks
    • 5% body weight loss: 2-3 months (at adequate dose)
    • 10% body weight loss: 4-6 months
    • Maximum weight loss: 12-16 months

    Week-by-Week Breakdown

    Weeks 1-4 (0.25 mg dose)

    The starting dose is sub-therapeutic for weight loss. Its primary purpose is to let your GI system adjust. Most patients notice mild appetite reduction and may lose 1-3 pounds, though some notice no change at this dose. Mild nausea is the most common side effect.

    Weeks 5-8 (0.5 mg dose)

    Appetite suppression becomes more noticeable. Weight loss of 3-6 pounds total is typical by the end of month two. You may notice eating less at meals and feeling less interest in snacking between meals.

    Weeks 9-16 (1.0-1.7 mg dose)

    This is where most patients see significant momentum. Weight loss accelerates as the dose reaches therapeutically effective levels. By 3-4 months, average weight loss is 5-8% of starting body weight. Clothes begin fitting noticeably differently.

    Months 5-8 (2.0-2.4 mg maintenance dose)

    At the full maintenance dose, appetite suppression is at its peak. Monthly weight loss may slow to 2-4 pounds per month as you weigh less, but the trajectory continues downward. Average cumulative weight loss reaches 10-13% of starting body weight.

    Months 9-16 (continued maintenance)

    Weight loss continues but gradually slows as your body approaches a new equilibrium. In STEP 1, average maximum weight loss was approximately 15-17% of starting body weight at 68 weeks. Some patients exceed 20%.

    Factors That Affect Speed of Results

    • Starting weight: Patients with higher starting BMI often lose more total weight.
    • Titration speed: Faster dose escalation (when tolerated) produces earlier results.
    • Diet quality: High-protein, nutrient-dense diets amplify results.
    • Exercise: Adding physical activity enhances weight loss and preserves muscle mass.
    • Individual biology: Genetic factors, gut microbiome composition, and metabolic rate all play a role.

    Frequently Asked Questions

    How fast does semaglutide work?

    Appetite reduction begins within 1-2 weeks. Measurable weight loss at 4-8 weeks. Most patients lose 5-8% of body weight by 3 months. Maximum results (15-17% average) at 12-16 months.

    When will I notice appetite changes on semaglutide?

    Most patients notice some appetite reduction within 1-2 weeks, even at the starting dose. The effect strengthens with each dose increase.

    Why is semaglutide not working for me yet?

    The starting dose is intentionally sub-therapeutic. Give the titration process at least 8-12 weeks. If you have been at 1.7 mg or higher for 8+ weeks without progress, discuss with your provider.

    Ready to start? Explore Trimi's semaglutide treatment programs with structured titration and ongoing clinical support.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading

    What does the published clinical evidence show for compounded semaglutide?

    Peer-reviewed evidence: Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021). Trimi offers compounded semaglutide starting at $99/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. — STEP 1, NEJM 2021
    Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. — STEP 4, JAMA 2021
    Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. — SELECT, NEJM 2023

    Key Takeaways

    • Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021)
    • Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. (Source: STEP 4, JAMA 2021)
    • Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. (Source: SELECT, NEJM 2023)
    • Semaglutide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Wegovy and Ozempic). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: February 15, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook
    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2021.3224
    3. Garvey WT, Batterham RL, Bhatta M, et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-022-02026-4
    4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2307563
    5. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa1607141
    6. Perkovic V, Tuttle KR, Rossing P, et al. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2403347

    Was this article helpful?

    Keep Reading

    Discover real semaglutide before and after results with a month-by-month timeline. See what weight loss to expect at 1, 3, 6, and 12 months based on clinical data.

    At 12 months on semaglutide, average weight loss reaches 14-17% of body weight. See complete STEP trial data, results distribution, health improvements, and maintenance strategies.

    At 6 months on semaglutide, average weight loss is 10-13% of body weight. See STEP trial data tables, results by BMI, health improvements, and strategies to maximize outcomes.

    Most patients lose 2-5 pounds in their first month on semaglutide. See clinical data, real-world averages by starting weight, and what changes to expect beyond the scale.

    Start your GLP-1 journey — from $99/mo

    Get Started